Corix Bioscience (Corix Bioscience) Debt-to-EBITDA : -0.05 (As of Sep. 2017)

Corix Bioscience Debt-to-EBITDA Chart

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Debt-to-EBITDA	Get a 7-Day Free Trial															-4.06	-0.43	-	-	-0.05

Competitive Comparison of Corix Bioscience's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corix Bioscience's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's Debt-to-EBITDA falls into.

Corix Bioscience Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Corix Bioscience's Debt-to-EBITDA for the fiscal year that ended in Dec. 2016 is calculated as

Corix Bioscience's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2017) EBITDA data.

Corix Bioscience  (GREY:CXBS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Corix Bioscience Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description